JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

Search

Owens & Minor Inc

Geschlossen

BrancheGesundheitswesen

3.45 -11.31

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.4

Max

3.89

Schlüsselkennzahlen

By Trading Economics

Einkommen

-59M

-84M

Verkäufe

-2B

682M

Gewinnspanne

-12.292

Angestellte

20,000

EBITDA

-100M

-40M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+45.59% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

69M

423M

Vorheriger Eröffnungskurs

14.76

Vorheriger Schlusskurs

3.45

Nachrichtenstimmung

By Acuity

100%

0%

360 / 373 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

Owens & Minor Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Nov. 2025, 21:44 UTC

Ergebnisse

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3. Nov. 2025, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3. Nov. 2025, 23:34 UTC

Market Talk

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3. Nov. 2025, 23:28 UTC

Ergebnisse

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3. Nov. 2025, 23:24 UTC

Ergebnisse

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3. Nov. 2025, 23:14 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Global Equities Roundup: Market Talk

3. Nov. 2025, 23:14 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3. Nov. 2025, 23:12 UTC

Ergebnisse

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3. Nov. 2025, 23:09 UTC

Ergebnisse

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3. Nov. 2025, 23:09 UTC

Ergebnisse

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3. Nov. 2025, 23:09 UTC

Ergebnisse

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3. Nov. 2025, 23:06 UTC

Market Talk
Ergebnisse

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3. Nov. 2025, 22:36 UTC

Market Talk
Ergebnisse

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3. Nov. 2025, 22:31 UTC

Ergebnisse

Franco-Nevada 3Q EPS $1.49 >FNV

3. Nov. 2025, 22:31 UTC

Ergebnisse

Franco-Nevada 3Q Rev $487.7M >FNV

3. Nov. 2025, 22:24 UTC

Market Talk

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3. Nov. 2025, 22:19 UTC

Akquisitionen, Fusionen, Übernahmen

Starbucks Agrees to Sell Stake in China Business -- WSJ

3. Nov. 2025, 21:59 UTC

Market Talk

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3. Nov. 2025, 21:54 UTC

Market Talk
Ergebnisse

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3. Nov. 2025, 21:54 UTC

Market Talk
Ergebnisse

Global Equities Roundup: Market Talk

3. Nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3. Nov. 2025, 21:49 UTC

Ergebnisse

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3. Nov. 2025, 21:40 UTC

Ergebnisse

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3. Nov. 2025, 21:31 UTC

Market Talk

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3. Nov. 2025, 21:19 UTC

Ergebnisse

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3. Nov. 2025, 21:11 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3. Nov. 2025, 21:11 UTC

Ergebnisse

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3. Nov. 2025, 21:07 UTC

Ergebnisse

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3. Nov. 2025, 21:05 UTC

Ergebnisse

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3. Nov. 2025, 21:05 UTC

Ergebnisse

Palantir Technologies 3Q Net $475.6M >PLTR

Peer-Vergleich

Kursveränderung

Owens & Minor Inc Prognose

Kursziel

By TipRanks

45.59% Vorteil

12-Monats-Prognose

Durchschnitt 5.78 USD  45.59%

Hoch 7 USD

Tief 4 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Owens & Minor Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

6 ratings

2

Buy

2

Halten

2

Sell

Technischer Score

By Trading Central

6.98 / 7.075Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

Weak Bullish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

360 / 373 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Owens & Minor Inc

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services. It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Mechanicsville, Virginia.
help-icon Live chat